Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer

Authors: Katherine A. Lyseng-Williamson

Published: 2020-09-29

DOI: 10.1007/s40265-020-01408-7

Source: Full article

Abstract

No abstract found.